Cybin (HELP) Cash from Financing Activities (2020 - 2026)

Cybin's (HELP) quarterly Cash from Financing Activities came in at -$169000.0 in Q1 2026, down 101.16% YoY from $14.6 million in Q1 2025, and down 100.12% on a QoQ basis from $143.7 million in Q4 2025.

Cybin (HELP) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Cybin (HELP) has 7 years of Cash from Financing Activities data on file, last reported at -$169000.0 in Q1 2026.

  • Quarterly Cash from Financing Activities fell 101.16% year-over-year to -$169000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198.2 million (up 1310.85% YoY) and the FY2026 annual result came in at $198.2 million, up 1306.45% from the prior year.
  • Cash from Financing Activities fell to -$169000.0 in Q1 2026, from $143.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $143.7 million in Q4 2025 to a low of -$271000.0 in Q3 2024.
  • A 5-year average of $27.1 million and a median of $2.6 million in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2024 — Cash from Financing Activities slumped 106.56% — and 2025, when it surged 112403.12%.
  • Tracing HELP's Cash from Financing Activities over 5 years: stood at $2.5 million in 2022, then soared by 1045.56% to $29.2 million in 2023, then tumbled by 100.44% to -$128000.0 in 2024, then surged by 112403.12% to $143.7 million in 2025, then slumped by 100.12% to -$169000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at -$169000.0 (Q1 2026), $143.7 million (Q4 2025), and $27000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.42 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -6.05 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -207,909.22
7 Royalty Pharma 33.72 Bn 35.84 Bn - -273.15 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 36.24 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 27.18 Mn
10 Cybin 417.29 Mn 417.29 Mn - -169,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -169,000.00
Mar 31, 2026 -169,000.00
Dec 31, 2025 143.75 Mn
Dec 31, 2025 143.75 Mn
Sep 30, 2025 27,000.00
Sep 30, 2025 27,000.00
Jun 30, 2025 54.63 Mn
Jun 30, 2025 54.63 Mn
Mar 31, 2025 14.62 Mn
Mar 31, 2025 14.62 Mn
Dec 31, 2024 -128,000.00
Dec 31, 2024 -128,000.00
Sep 30, 2024 -271,000.00
Sep 30, 2024 -271,000.00
Jun 30, 2024 -172,000.00
Jun 30, 2024 -172,000.00
Mar 31, 2024 141.64 Mn
Mar 31, 2024 141.64 Mn
Dec 31, 2023 29.19 Mn
Dec 31, 2023 29.19 Mn